Research and Development

LUMICKS announced that new research findings published in Translational Medicine detailed a novel design strategy for preventing tumour escape through …

Engitix has announced the close of its $54m Series A financing, as well as a strategic collaboration, with Dompé farmaceutici …

Galapagos NV, the Belgian parent company of Galapagos Biotech Ltd, have announced that Jyseleca® (filgotinib 200mg tablets) has been granted …

Accord Healthcare have announced the UK launch of generic lenalidomide, available for the treatment of adult patients with multiple myeloma, …

The SMC has accepted AstraZeneca’s Tagrisso (osimertinib) for use as monotherapy for the first-line treatment of adult patients with locally …

The Biden administration announced new plans to increase COVID-19 protection in schools in the US, as the Omicron variant continues …

Biotechnology company Novavax, alongside SK bioscience, a vaccine business subsidiary of Korea-based SK Group, announced that South Korea’s Ministry of …

Repeating booster doses of the original COVID-19 vaccines is not a viable strategy against emerging variants, WHO has shared, predicting …

Vertex Pharmaceuticals have announced the MHRA approval of the label extension of Kaftrio® (ivacaftor/tezacaftor/elexacaftor) in a combination regimen with ivacaftor, …

India’s drug regulator has granted approval to Bharat Biotech, for late stage trials of its nasal COVID-19 vaccine to be …

The FDA has granted a  breakthrough therapy designation to Cullian Oncology’s CLN-081, in certain patients with locally advanced or metastatic …

Nanomedical company NaNotics have announced a research collaboration with Mayo Clinic, to develop a NaNot that targets the soluble form …

NICE has issued a positive Final Appraisal Document (FAD) recommending PONVORY® (ponesimod) as an option in England and Wales for …

Avacta Group plc, a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® …

A new South African study suggests that there are reduced risks of hospitalisation and severe disease in people infected with …